Investor FAQs

Show All
When was G1 founded?
G1 was founded in 2008.
Where is G1 incorporated?
G1 was incorporated in Delaware in May 2008 as G-Zero Therapeutics, Inc. and its name was changed to G1 Therapeutics, Inc. in October 2012.
Where is G1's corporate headquarters?
79 T.W. Alexander Drive
4501 Research Commons, Suite 100
Research Triangle Park, NC 27709
(919) 213-9835
Who are the members of G1's board of directors?
You can view our board of directors by visiting the “Board of Directors” section of our website.
Who are the members of G1's management team?
You can view our management team by visiting the “Management Team” section of our website.
When is G1's fiscal year-end date?
December 31.
Who is G1's independent registered public accounting firm?
PricewaterhouseCoopers LLP.
On which exchange is G1 listed and what is the ticker symbol?
G1 is traded on the Nasdaq Global Select Market under the symbol “GTHX.”
When did G1 go public?
G1 went public on May 16, 2017.
How can I purchase shares?
Shares can be purchased through a stockbroker of your choice.
Does G1 have a direct stock purchase plan?
G1 does not currently offer a direct stock purchase plan.
Does G1 pay dividends and have a dividend reinvestment program?
Currently, G1 does not offer a dividend or a dividend reinvestment program.
What is G1's CUSIP number?
3621LQ109.
Who is G1's transfer agent and how do I contact them?
G1’s transfer agent is Computershare Trust Company, N.A. You can find more information about how to contact Computershare Trust Company at:

Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(877) 373-6374
https://www-us.computershare.com/Investor/Contact
How can I replace my lost stock certificates?
If you have misplaced your stock certificates, please contact our transfer agent, Computershare. There may be a fee involved for replacing lost stock certificates.
How do I report a change of mailing address?
You must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A., https://www-us.computershare.com/Investor, by U.S. mail. Each stockholder in question must sign a request for an address change.
Where can I find your Annual Report, 10-K and other investor materials?
Our Annual Report can be found here. SEC filings, including our 10-K, can be found here. Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov
Where can I find recent G1 press releases?
You can view our recent press releases by visiting the “Press Releases” section of our website.
How do I contact Investor Relations with a question or request?
For investor-related questions please contact:

Jeff Macdonald
G1 Therapeutics, Inc.
917-371-0940
jmacdonald@g1therapeutics.com
Who can I contact if I am a member of the media?
For media inquiries please contact:

Jeff Macdonald
G1 Therapeutics, Inc.
917-371-0940
jmacdonald@g1therapeutics.com
Where can I find more information on G1's R&D programs?
You can view information on our development programs by visiting the “Pipeline” section of our website.
How can I sign up to receive G1's press releases and other company information?
Please click here to sign up for company updates.
If I have questions regarding G1 that have not been answered, whom should I contact?
Jeff Macdonald
G1 Therapeutics, Inc.
917-371-0940
jmacdonald@g1therapeutics.com